. Clinical Transfusion Medicine Committee of the, AABB“Red blood cell transfusion: a clinical practice guideline from the AABB*”. Annals of Internal Medicine157 (1): 49–58. (July 2012). doi:10.7326/0003-4819-157-1-201206190-00429. PMID22751760.
“Transfusion strategies for acute upper gastrointestinal bleeding”. The New England Journal of Medicine368 (1): 11–21. (January 2013). doi:10.1056/NEJMoa1211801. PMID23281973.
“The international experience of bacterial screen testing of platelet components with an automated microbial detection system: a need for consensus testing and reporting guidelines”. Transfusion Medicine Reviews28 (2): 61–71. (April 2014). doi:10.1016/j.tmrv.2014.01.001. PMID24636779.
“Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice”. Transfusion46 (9): 1553–1560. (September 2006). doi:10.1111/j.1537-2995.2006.00939.x. PMID16965583.
“Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation”. Transfusion51 (7): 1397–1404. (July 2011). doi:10.1111/j.1537-2995.2010.02984.x. PMID21155832.
“Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation”. Transfusion Medicine Reviews22 (2): 133–153. (April 2008). doi:10.1016/j.tmrv.2007.12.003. PMID18353253.
“Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to support pathogen reduction technology”. Photochemistry and Photobiology80 (3): 609–615. (2004). doi:10.1562/0031-8655(2004)080<0609:TNSIAQ>2.0.CO;2. PMID15382964.
“A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology”. Transfusion50 (11): 2362–2375. (November 2010). doi:10.1111/j.1537-2995.2010.02694.x. PMID20492615.
“The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends”. Transfusion and Apheresis Science35 (1): 5–17. (August 2006). doi:10.1016/j.transci.2006.01.007. PMID16935562.
“Clinical impact of blood storage lesions”. American Journal of Hematology85 (2): 117–122. (February 2010). doi:10.1002/ajh.21599. PMID20052749.
“In vivo regeneration of red cell 2,3-diphosphoglycerate following transfusion of DPG-depleted AS-1, AS-3 and CPDA-1 red cells”. British Journal of Haematology71 (1): 131–136. (January 1989). doi:10.1111/j.1365-2141.1989.tb06286.x. PMID2492818.
“Artificial microvascular network: a new tool for measuring rheologic properties of stored red blood cells”. Transfusion52 (5): 1010–1023. (May 2012). doi:10.1111/j.1537-2995.2011.03418.x. PMID22043858.
“The use of the mechanical fragility test in evaluating sublethal RBC injury during storage”. Vox Sanguinis99 (4): 325–331. (November 2010). doi:10.1111/j.1423-0410.2010.01365.x. PMID20673245.
“Estimating the cost of blood: past, present, and future directions”. Best Practice & Research. Clinical Anaesthesiology21 (2): 271–289. (June 2007). doi:10.1016/j.bpa.2007.01.002. PMID17650777.
“Perioperative blood transfusion is associated with worse clinical outcomes in resected lung cancer”. The Annals of Thoracic Surgery97 (5): 1827–1837. (May 2014). doi:10.1016/j.athoracsur.2013.12.044. PMID24674755.
“Taming the immune system through transfusion in oncology patients”. Transfusion and Apheresis Science56 (3): 310–316. (June 2017). doi:10.1016/j.transci.2017.05.017. PMID28651910.
“Hepatic resection and blood transfusion increase morbidity after cytoreductive surgery and HIPEC for colorectal carcinomatosis”. Clinical & Translational Oncology22 (11): 2032–2039. (November 2020). doi:10.1007/s12094-020-02346-2. PMID32277348.
Smith, DA; Perry, PJ (1992). “The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents”. Ann Pharmacother26 (5): 653–659. doi:10.1177/106002809202600510. PMID1591427.
. International Consensus Conference on Transfusion Outcomes Group“Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes”. Transfusion Medicine Reviews25 (3): 232–246.e53. (July 2011). doi:10.1016/j.tmrv.2011.02.001. PMID21498040.
Lindeboom, G. A. (1954). “The Story of a Blood Transfusion to a Pope”. Journal of the History of Medicine and Allied SciencesIX (4): 455–459. doi:10.1093/jhmas/IX.4.455. PMID13212030.
“The first direct human blood transfusion: the forgotten legacy of George W. Crile”. Neurosurgery64 (3 Suppl): ons20–26; discussion ons26–27. (March 2009). doi:10.1227/01.NEU.0000334416.32584.97. PMID19240569. "[...] the first successful blood transfusion performed between 2 brothers on August 6, 1906, at St. Alexis Hospital, Cleveland, OH."
Lewisorn, Richard (1940). “CITRATE METHOD OF BLOOD TRANSFUSION”. Journal of the American Medical Association114 (16): 1576. doi:10.1001/jama.1940.02810160078030.
“Taking credit: the Canadian Army Medical Corps and the British conversion to blood transfusion in WWI”. Journal of the History of Medicine and Allied Sciences56 (3): 238–277. (July 2001). doi:10.1093/jhmas/56.3.238. PMID11552401.
“Blood transfusion in World War I: the roles of Lawrence Bruce Robertson and Oswald Hope Robertson in the "most important medical advance of the war"”. Transfusion Medicine Reviews23 (3): 232–236. (July 2009). doi:10.1016/j.tmrv.2009.03.007. PMID19539877.
Loutit, J. F.; Mollison, P. L.; Young, I. Maureen; Lucas, E. J. (16 December 1943). “Citric Acid-Sodium Citrate-Glucose Mixtures for Blood Storage”. Quarterly Journal of Experimental Physiology and Cognate Medical Sciences32 (3): 183–202. doi:10.1113/expphysiol.1943.sp000882.
. Clinical Transfusion Medicine Committee of the, AABB“Red blood cell transfusion: a clinical practice guideline from the AABB*”. Annals of Internal Medicine157 (1): 49–58. (July 2012). doi:10.7326/0003-4819-157-1-201206190-00429. PMID22751760.
“Transfusion strategies for acute upper gastrointestinal bleeding”. The New England Journal of Medicine368 (1): 11–21. (January 2013). doi:10.1056/NEJMoa1211801. PMID23281973.
“The international experience of bacterial screen testing of platelet components with an automated microbial detection system: a need for consensus testing and reporting guidelines”. Transfusion Medicine Reviews28 (2): 61–71. (April 2014). doi:10.1016/j.tmrv.2014.01.001. PMID24636779.
“Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice”. Transfusion46 (9): 1553–1560. (September 2006). doi:10.1111/j.1537-2995.2006.00939.x. PMID16965583.
“Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation”. Transfusion51 (7): 1397–1404. (July 2011). doi:10.1111/j.1537-2995.2010.02984.x. PMID21155832.
“Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation”. Transfusion Medicine Reviews22 (2): 133–153. (April 2008). doi:10.1016/j.tmrv.2007.12.003. PMID18353253.
“Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to support pathogen reduction technology”. Photochemistry and Photobiology80 (3): 609–615. (2004). doi:10.1562/0031-8655(2004)080<0609:TNSIAQ>2.0.CO;2. PMID15382964.
“A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology”. Transfusion50 (11): 2362–2375. (November 2010). doi:10.1111/j.1537-2995.2010.02694.x. PMID20492615.
“The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends”. Transfusion and Apheresis Science35 (1): 5–17. (August 2006). doi:10.1016/j.transci.2006.01.007. PMID16935562.
“Clinical impact of blood storage lesions”. American Journal of Hematology85 (2): 117–122. (February 2010). doi:10.1002/ajh.21599. PMID20052749.
“In vivo regeneration of red cell 2,3-diphosphoglycerate following transfusion of DPG-depleted AS-1, AS-3 and CPDA-1 red cells”. British Journal of Haematology71 (1): 131–136. (January 1989). doi:10.1111/j.1365-2141.1989.tb06286.x. PMID2492818.
“Artificial microvascular network: a new tool for measuring rheologic properties of stored red blood cells”. Transfusion52 (5): 1010–1023. (May 2012). doi:10.1111/j.1537-2995.2011.03418.x. PMID22043858.
“The use of the mechanical fragility test in evaluating sublethal RBC injury during storage”. Vox Sanguinis99 (4): 325–331. (November 2010). doi:10.1111/j.1423-0410.2010.01365.x. PMID20673245.
“Estimating the cost of blood: past, present, and future directions”. Best Practice & Research. Clinical Anaesthesiology21 (2): 271–289. (June 2007). doi:10.1016/j.bpa.2007.01.002. PMID17650777.
“Perioperative blood transfusion is associated with worse clinical outcomes in resected lung cancer”. The Annals of Thoracic Surgery97 (5): 1827–1837. (May 2014). doi:10.1016/j.athoracsur.2013.12.044. PMID24674755.
“Taming the immune system through transfusion in oncology patients”. Transfusion and Apheresis Science56 (3): 310–316. (June 2017). doi:10.1016/j.transci.2017.05.017. PMID28651910.
“Hepatic resection and blood transfusion increase morbidity after cytoreductive surgery and HIPEC for colorectal carcinomatosis”. Clinical & Translational Oncology22 (11): 2032–2039. (November 2020). doi:10.1007/s12094-020-02346-2. PMID32277348.
Smith, DA; Perry, PJ (1992). “The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents”. Ann Pharmacother26 (5): 653–659. doi:10.1177/106002809202600510. PMID1591427.
. International Consensus Conference on Transfusion Outcomes Group“Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes”. Transfusion Medicine Reviews25 (3): 232–246.e53. (July 2011). doi:10.1016/j.tmrv.2011.02.001. PMID21498040.
Hohenhaus, A. E. (1992年12月). “Canine blood transfusions”. Problems in Veterinary Medicine. pp. 612–624. 2023年5月24日閲覧。
Lindeboom, G. A. (1954). “The Story of a Blood Transfusion to a Pope”. Journal of the History of Medicine and Allied SciencesIX (4): 455–459. doi:10.1093/jhmas/IX.4.455. PMID13212030.
“The first direct human blood transfusion: the forgotten legacy of George W. Crile”. Neurosurgery64 (3 Suppl): ons20–26; discussion ons26–27. (March 2009). doi:10.1227/01.NEU.0000334416.32584.97. PMID19240569. "[...] the first successful blood transfusion performed between 2 brothers on August 6, 1906, at St. Alexis Hospital, Cleveland, OH."
“Taking credit: the Canadian Army Medical Corps and the British conversion to blood transfusion in WWI”. Journal of the History of Medicine and Allied Sciences56 (3): 238–277. (July 2001). doi:10.1093/jhmas/56.3.238. PMID11552401.
“Blood transfusion in World War I: the roles of Lawrence Bruce Robertson and Oswald Hope Robertson in the "most important medical advance of the war"”. Transfusion Medicine Reviews23 (3): 232–236. (July 2009). doi:10.1016/j.tmrv.2009.03.007. PMID19539877.
